Impact of nutrients on insulin-like growth factor-I, insulin-like growth factor binding protein-3 and their ratio in African American and white males

Public Health Nutrition

Volumn 10, Issue 1, 2007, Pages 97-105

  McGreevy, Katharine M ^a,b   Hoel, Brian D ^c   Lipsitz, Stuart R ^d   Hoel, David G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

IGF I; IGFBP 3; Nutrition; Race

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CALCIUM INTAKE; CANCER RISK; CANCER SCREENING; HUMAN; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NUTRIENT CONTENT; NUTRITION; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; VEGETABLE; BLOOD; CAUCASIAN; CROSS-SECTIONAL STUDY; DIET; METABOLISM; MIDDLE AGED; PROSTATE TUMOR; STATISTICAL MODEL;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIET; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LINEAR MODELS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUESTIONNAIRES;

EID: 33847783258     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980007217999     Document Type: Article

References (56)

1. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nature Reviews. Cancer 2004; 4(7): 505-18.
2. Pollak M. Insulin-like growth factor physiology and cancer risk. European Journal of Cancer 2000; 36(10): 1224-8.
3. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. Journal of the National Cancer Institute 2000; 92(18): 1472-89.
4. Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. Journal of Biological Chemistry 1997; 272(18): 12181-8.
5. Grimberg A. P53 and IGFBP-3: apoptosis and cancer protection. Molecular Genetics & Metabolism 2000; 70(2): 85-98.
6. Pollak M. Insulin-like growth factors and prostate cancer. Epidemiologic Reviews 2001; 23(1): 59-66.
7. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998; 279(5350): 563-6.
8. Harman SM, Metter EJ, Blackman MR, Landis PK, Carter HB; Baltimore Longitudinal Study on Aging. Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. Journal of Clinical Endocrinology and Metabolism 2000; 85(11): 4258-65.
9. Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH, et al. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. Journal of the National Cancer Institute 2000; 92(23): 1910-7.
10. Djavan B, Bursa B, Seitz C, SoeregiG, Remzi M, Basharkhah A, et al. Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection. Urology 1999; 54(4): 603-6.
11. Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, et al. Insulin-like growth factors and prostate cancer: a population-based case - control study in China. Cancer Epidemiology, Biomarkers & Prevention 2001; 10(5): 421-7.
12. Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami HO. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. British Journal of Cancer 1997; 76(9): 1115-8.
13. Wolk A, Mantzoros CS, Andersson SO, Bergstrom R, Signorello LB, Lagiou P, et al. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. Journal of the National Cancer Institute 1998; 90(12): 911-5.
14. Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, et al. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. Journal of the National Cancer Institute 2002; 94(14): 1099-106.
15. Pollak M, Beamer W, Zhang JC. Insulin-like growth factors and prostate cancer. Cancer Metastasis Reviews 1999; 17(4): 383-90.
16. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocrine Reviews 1994; 15(1): 80-101.
17. Platz EA, Pollak MN, Rimm EB, Majeed N, Tao YZ, Willett WC, et al. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiology, Biomarkers & Prevention 1999; 8(12): 1107-10.
18. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Koumantaki Y, Mantzoros CS. Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. Journal of Clinical Oncology 1999; 17(10): 3291-8.
19. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. Journal of Clinical Investigation 1996; 98(11): 2612-5.
20. Ketelslegers JM, Maiter D, Maes M, Underwood LE, Thissen JP. Nutritional regulation of insulin-like growth factor-I. Metabolism: Clinical and Experimental 1995; 44(10 Suppl. 4): 50-7.
21. Ketelslegers JM, Maiter D, Maes M, Underwood LE, Thissen JP. Nutritional regulation of the growth hormone and insulin-like growth factor-binding proteins. Hormone Research 1996; 45(3-5): 252-7.
22. Soliman AT, Hassan AE, Aref MK, Hintz RL, Rosenfeld RG, Rogol AD. Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation. Pediatric Research 1986; 20(11): 1122-30.
23. Clinton SK, Giovannucci E. Diet, nutrition, and prostate cancer. Annual Review of Nutrition 1998; 18: 413-40.
24. World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR). Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC: WCRF/AICR, 1997.
25. Dunn S, Kari F, French J, Leininger J, Travlos G, Wilson R, et al. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Research 1997; 57(21): 4667-72.
26. Mukherjee P, Sotnikov AV, Mangian HJ, Zhou JR, Visek WJ, Clinton SK. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. Journal of the National Cancer Institute 1999; 91(6): 512-23.
27. Kritchevsky D. Caloric restriction and experimental carcino-genesis. Advances in Experimental Medicine and Biology 1992; 322: 131-41.
28. Tricoli JV, Winter DL, Hanlon AL, Raysor SL, Watkins-Bruner D, Pinover WH, et al. Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer. Urology 1999; 54(1): 178-82.
29. Wright NM, Renault J, Willi S, Veldhuis JD, Pandey JP, Gordon L, et al. Greater secretion of growth hormone in black than in white men: possible factor in greater bone mineral density - a clinical research center study. Journal of Clinical Endocrinology and Metabolism 1995; 80(8): 2291-7.
30. DeLellis K, Rinaldi S, Kaaks R, Kolonel L, Henderson B, Le Marchand L. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): The Multiethnic Cohort. Cancer Epidemiology, Biomarkers & Prevention 2004; 13(9): 1444-51.
31. McGreevy K, Hoel B, Lipsitz S, Bissada N, Hoel D. Racial and anthropometric differences in plasma levels of insulin like growth factor I and insulin like growth factor binding protein-3. Urology 2005; 66(3): 587-92.
32. Saxe GA, Hebert JR, Carmody JF, Kabat-Zinn J, Rosenzweig PH, Jarzobski D, et al. Can diet in conjunction with stress reduction affect the rate of increase in prostate specific antigen after biochemical recurrence of prostate cancer? Journal of Urology 2001; 166(6): 2202-7.
33. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, et al. Prostate cancer and supplementation with a-tocopherol and β-carotene: incidence and mortality in a controlled trial. Journal of the National Cancer Institute 1998; 90(6): 440-6.
34. Nomura AM, Lee J, Stemmermann GN, Combs GF Jr. Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention 2000; 9(9): 883-7.
35. Willett WC, Polk BF, Morris JS, Stampfer MJ, Pressel S, Rosner B, et al. Prediagnostic serum selenium and risk of cancer. Lancet 1983; 2(8342): 130-4.
36. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Research 1999; 59(6): 1225-30.
37. National Institutes of Health. Racial/Ethnic Patterns of Cancer in the United States, 1988-1992. Bethesda, MD: National Cancer Institute, 1996.
38. Stanford JL, Stephenson RA, Coyle LM, Cerhan J, Correa R, Eley JW, et al. Prostate Cancer Trends 1973-1995. Report No. 99-4543. Bethesda, MD: National Cancer Institute, 1999.
39. Block G, Hartman AM, Naughton D. A reduced dietary questionnaire: development and validation. Epidemiology 1990; 1(1): 58-64.
40. Draper N, Smith H. Applied Regression Analysis, 2nd ed. New York: John Wiley and Son, 1981.
41. Heald AH, Cade JE, Cruickshank JK, Anderson S, White A, Gibson JM. The influence of dietary intake on the insulin-like growth factor (IGF) system across three ethnic groups: a population-based study. Public Health Nutrition 2003; 6(2): 175-80.
42. Mucci LA, Tamimi R, Lagiou P, Trichopoulou A, Benetou V, Spanos E, et al. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU International 2001; 87(9): 814-20.
43. Teramukai S, Rohan T, Eguchi H, Oda T, Shinchi K, Kono S. Anthropometric and behavioral correlates of insulin-like growth factor I and insulin-like growth factor binding protein 3 in middle-aged Japanese men. American Journal of Epidemiology 2002; 156(4): 344-8.
44. Santolaria F, Gonzalez-Gonzalez G, Gonzalez-Reimers E, Martinez-Riera A, Milena A, Rodgiguez-Moreno F, et al. Effects of alcohol and liver cirrhosis on the GH-IGF-I axis. Alcohol and Alcoholism 1995; 30(6): 703-8.
45. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Mantzoros C. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. Journal of Clinical Oncology 1999; 17(3): 813-7.
46. Goodman-Gruen D, Barrett-Connor E. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. American Journal of Epidemiology 1997; 145(11): 970-6.
47. Holmes MD, Pollak MN, Willett WC, Hankinson SE. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiology, Biomarkers & Prevention 2002; 11(9): 852-61.
48. Gunnell D, Oliver SE, Peters TJ, Donovan JL, Persad R, Maynard M, et al. Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. British Journal of Cancer 2003; 88(11): 1682-6.
49. Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, Rimm EB, et al. Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiology, Biomarkers & Prevention 2003; 12(2): 84-9.
50. Heaney RP, McCarron DA, Dawson-Hughes B, Oparil S, Berga SL, Stern JS, et al. Dietary changes favorably affect bone remodeling in older adults. Journal of the American Dietetic Association 1999; 99(10): 1228-33.
51. Allen NE, Appleby PN, Davey GK, Key TJ. Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men. British Journal of Cancer 2000; 83(1): 95-7.
52. Ma J, Giovannucci E, Pollak M, Chan JM, Gaziano JM, Willett W, et al. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. Journal of the National Cancer Institute 2001; 93(17): 1330-6.
53. Chan JM, Giovannucci E, Andersson SO, Yuen J, Adami HO, Wolk A. Dairy products, calcium, phosphorus, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes & Control 1998; 9(6): 559-66.
54. Giovannucci E, Rimm EB, Wolk A, Ascherio A, Stampfer MJ, Colditz GA, et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Research 1998; 58(3): 442-7.
55. Kristal AR, Cohen JH, Qu P, Stanford JL. Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention 2002; 11(8): 719-25.
56. Chan JM, Giovannucci EL. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiologic Reviews 2001; 23(1): 87-92.